SCHEMBL5515650

SCHEMBL5515650

CN1C(=N)NC(c2ccccc2)(C2CCCCC2)C1=O

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 4/20 0.48
BACE2 Q9Y5Z0 4/20 0.48
APP P05067 1/20 0.48
CTSD P07339 1/20 0.48
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
SLC6A3 Q01959 1/20 0.39
PRMT5 O14744 1/20 0.39
WDR77 Q9BQA1 1/20 0.39
ATM Q13315 2/20 0.38
PPME1 Q9Y570 1/20 0.38
TSHR P16473 1/20 0.38
CYP2C19 P33261 1/20 0.38
CHRM2 P08172 3/20 0.37
CHRM3 P20309 3/20 0.37
CHRM4 P08173 2/20 0.36
CHRM5 P08912 2/20 0.36
CHRM1 P11229 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4597602 0.99 BACE1 (0.46) BACE1BACE2APPCTSDSLC6A2
SCHEMBL5517793 0.96 BACE1 (0.43) BACE1BACE2APPCTSDSLC6A2
SCHEMBL5526888 0.92 BACE1 (0.42) BACE1BACE2APPCTSDPRMT5
SCHEMBL4599371 0.89 APP (0.40) BACE1BACE2APPCTSD
SCHEMBL4599019 0.88 POLB (0.37) BACE1BACE2APPCTSDSLC6A2
SCHEMBL4598839 0.87 BACE1 (0.36) BACE1BACE2APPCTSDSLC6A2
SCHEMBL4599783 0.87 BACE1 (0.36) BACE1BACE2APPCTSDSLC6A4
SCHEMBL4598984 0.86 BACE1 (0.40) BACE1BACE2APPCTSDPRMT5
SCHEMBL5521710 0.86 CHRM2 (0.40) BACE1BACE2APPCTSDCHRM2
SCHEMBL2967486 0.86 BACE1 (0.39) BACE1BACE2APPCTSDSLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070027199-A1 Cycloalkyl amino-hydantoin compounds and use thereof for beta-secretase modulation WYETH (US) 2007-02-01 US claimed
US-20070027199-A1 Cycloalkyl amino-hydantoin compounds and use thereof for beta-secretase modulation WYETH (US) 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027199-A1 Cycloalkyl amino-hydantoin compounds and use thereof for beta-secretase modulation BACE1, BACE2, APP BACE1 1/4885BACE2 2/4885APP 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.